Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
New England Journal of Medicine · 31.10.2024 · 391 (17) · 1584-1596
DOI: 10.1056/nejmoa2404625 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 31.10.2024. Verfasst von Nicholas C Turner und 21 weiteren Autor:innen. Beteiligte Einrichtung: From the Royal Marsden Hospital and Institute of Cancer Research (N.C.T.) and the Centre for Experimental Cancer Medicine, Barts Cancer Institute, Qu…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, Male. Die Arbeit wurde bisher 321-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: F. Hoffmann–La Roche, F. Hoffmann-La Roche Ltd.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Royal Marsden Hospital and Institute of Cancer Research (N.C.T.) and the Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London (P. Schmid), London, and Roche, Welwyn G…
Förderung
- F. Hoffmann–La Roche
- F. Hoffmann-La Roche Ltd
Zitieren
APA
Turner, N. C., Im, S. A., Saura, C., Juric, D., Loibl, S., Kalinsky, K., Schmid, P., Loi, S., Sunpaweravong, P., Musolino, A., Li, H., Zhang, Q., Nowecki, Z., Leung, R., Thanopoulou, E., Shankar, N., Lei, G., Stout, T. J., Hutchinson, K. E., …, & Jhaveri, K. L. (2024). Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer. New England Journal of Medicine, 391(17), 1584-1596. https://doi.org/10.1056/nejmoa2404625
Vancouver
Turner NC, Im SA, Saura C, Juric D, Loibl S, Kalinsky K, et al. Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer. New England Journal of Medicine. 2024;391(17):1584-1596. doi:10.1056/nejmoa2404625
BibTeX
@article{Turner2024,
author = {Turner, Nicholas C and Im, Seock-Ah and Saura, Cristina and Juric, Dejan and Loibl, Sibylle and Kalinsky, Kevin and Schmid, Peter and Loi, Sherene and Sunpaweravong, Patrapim and Musolino, Antonino and Li, Huiping and Zhang, Qingyuan and Nowecki, Zbigniew and Leung, Roland and Thanopoulou, Eirini and Shankar, Noopur and Lei, Guiyuan and Stout, Thomas J and Hutchinson, Katherine E and Schutzman, Jennifer L and Song, Chunyan and Jhaveri, Komal L},
title = {Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {17},
pages = {1584--1596},
doi = {10.1056/nejmoa2404625}
}
EUVIMED